Metraipolis › archive › dc_bd31ad83a618

Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinoma — Europe PMC PMID:42902345

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42902345
DOI
10.1186/s40164-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-10-31T21:53:54.007Z
SHA-256 of the archived text
910ba40ea7c643603c8aabdf82c1cd7d5091b0747736bccbfd17a4687ae4e3db
Stable URL of this page
https://metraipolis.com/documento/dc_bd31ad83a618

How to cite

Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinoma — Europe PMC PMID:42902345 — Europe PMC (en), https://europepmc.org/article/MED/42902345 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd31ad83a618 (Metraipolis archive dc_bd31ad83a618, sha256 910ba40ea7c643603c8aabdf82c1cd7d5091b0747736bccbfd17a4687ae4e3db)
BibTeX
@misc{dcbd31ad83a618,
  title = {Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinoma — Europe PMC PMID:42902345},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42902345},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd31ad83a618; sha256 910ba40ea7c643603c8aabdf82c1cd7d5091b0747736bccbfd17a4687ae4e3db},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42902345. Agents can read the archived copy with the MCP tool read_document.